EUVIMEDEUVIMED entdecken
Crossref

Molecular features and prognostic factors of locally advanced microsatellite instability-high gastric cancer

Kenichiro Furukawa, Keiichi Hatakeyama, Masanori Terashima iD, Kenichi Urakami, Yusuke Koseki, Keiichi Fujiya, Yutaka Tanizawa, Etsuro Bando, Ken Yamaguchi

Gastric Cancer · 2024

DOI: 10.1007/s10120-024-01506-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gastric Cancer, 2024. Verfasst von Kenichiro Furukawa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastric Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms, Microsatellite Instability, Gastrectomy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Microsatellite instability-high (MSI-H) tumors are distinct molecular subtypes in gastric cancer. However, a few studies have comprehensively reported the molecular features of MSI-H tumors and their prognostic factors in locally advanced gastric cancer. This study aimed to clarify the molecular features and prognostic factors of locally advanced MSI-H gastric cancer. METHODS: This study included 499 patients with locally advanced gastric cancer who underwent radical gastrectomy. We evaluated the MSI status and compared with previously published whole-exome sequencing, panel sequencing, and gene expression profiling data. Clinicopathological characteristics and molecular profiles were compared between patients with MSI-H and microsatellite stable (MSS) gastric cancer. A subgroup analysis of survival was performed in patients with MSI-H gastric cancer. RESULTS: MSI-H tumors were detected in 79 of 499 patients (15.8%). MSI-H tumors were associated with an increased tumor mutational burden, MLH1 downregulation, CD274 (PD-L1) upregulation, and enrichment of cell cycle pathways. Among patients with MSI-H gastric cancer, the disease-specific survival (DSS) tended to be better in the surgery plus tegafur, gimeracil, and oteracil potassium (S-1) adjuvant chemotherapy group than in the surgery alone group, especially for stage III patients. Furthermore, DSS was better in the T cell-inflamed gene expression signature-high group, and it tended to be worse in the non-solid type poorly differentiated adenocarcinoma group. CONCLUSIONS: The molecular features and prognostic factors of locally advanced MSI-H gastric cancer were clarified. S-1 adjuvant chemotherapy appears to be beneficial, and the T cell-inflamed gene expression signature and histopathological type are prognostic factors in MSI-H tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsMicrosatellite InstabilityGastrectomyHumansFemaleMalePrognosisAgedMiddle AgedBiomarkers, TumorTegafurAdultDrug CombinationsOxonic AcidAged, 80 and overB7-H1 AntigenSurvival RateMutationGene Expression ProfilingExome SequencingMutL Protein Homolog 1Gene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

Gastric cancerLocally advancedMicrosatellite instability-highMolecular featuresPrognostic factor

Substanzen

Biomarkers, TumorTegafurDrug CombinationsOxonic AcidS 1 (combination)CD274 protein, humanB7-H1 AntigenMutL Protein Homolog 1MLH1 protein, human

Autor:innen und Institutionen

  • Division of Gastric Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Cancer Multiomics Division, Shizuoka Cancer Center Research Institute, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Division of Gastric Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan. m.terashima@scchr.jp.
  • Cancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

ORCID-Profile: Masanori Terashima

Zitieren

APA

Furukawa, K., Hatakeyama, K., Terashima, M., Urakami, K., Koseki, Y., Fujiya, K., Tanizawa, Y., Bando, E., & Yamaguchi, K. (2024). Molecular features and prognostic factors of locally advanced microsatellite instability-high gastric cancer. Gastric Cancer. https://doi.org/10.1007/s10120-024-01506-5

Vancouver

Furukawa K, Hatakeyama K, Terashima M, Urakami K, Koseki Y, Fujiya K, et al. Molecular features and prognostic factors of locally advanced microsatellite instability-high gastric cancer. Gastric Cancer. 2024. doi:10.1007/s10120-024-01506-5

BibTeX
@article{Furukawa2024,
  author = {Furukawa, Kenichiro and Hatakeyama, Keiichi and Terashima, Masanori and Urakami, Kenichi and Koseki, Yusuke and Fujiya, Keiichi and Tanizawa, Yutaka and Bando, Etsuro and Yamaguchi, Ken},
  title = {Molecular features and prognostic factors of locally advanced microsatellite instability-high gastric cancer},
  journal = {Gastric Cancer},
  year = {2024},
  doi = {10.1007/s10120-024-01506-5}
}
Kostenlos starten →